Kepler Capital Sticks to Their Sell Rating for PORR AG (0J04)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, New is a 2-star analyst with an average return of 2.8% and a 66.67% success rate. New covers the Industrials sector, focusing on stocks such as Andritz AG, Palfinger AG, and STRABAG.
PORR AG has an analyst consensus of Strong Buy, with a price target consensus of €35.90.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results
WARREN, N.J., July 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2025 financial results and provide an update on the company's business and outlook on Thursday, August 7, at 4:30 p.m. ET. To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in for the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days. ABOUT PTC THERAPEUTICS, is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit and follow on Facebook, X, and LinkedIn. For more information, please contact: Investors:Ellen Cavaleri+1 (615) 618-8228ecavaleri@ Media:Jeanine Clemente+1 (908) 912-9406jclemente@ View original content to download multimedia: SOURCE PTC Therapeutics, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
2 hours ago
- Bloomberg
Netflix Using Startup Runway AI's Video Tools for Production
Netflix Inc. has begun using artificial intelligence video generation software from startup Runway AI, testing the waters with a technology that's controversial in Hollywood. Netflix is currently using the New York-based startup's tools in content production, according to a person familiar with the matter, who asked not to be named in order to discuss private conversations. Netflix declined to comment.
Yahoo
5 hours ago
- Yahoo
NY Fed survey finds easier access to auto loans, mortgage refinancing
By Michael S. Derby (Reuters) -U.S. households fared far better when applying for credit for mortgage refinancing or auto loans in June, new figures on credit access from the Federal Reserve Bank of New York show. The bank said Monday that rejected applications for mortgage refinancing dropped to 15% in June, versus 42% in February, which was the worst rejection-rate month in data that goes back to the fall of 2013. The rejection rate for auto loans also retreated, though less dramatically, to 7% in June from February's 14%. Overall credit applications and rejection rates during the last year largely remained steady, the bank said. The findings come from the bank's Survey of Consumer Expectations, which is most closely watched for its monthly readings on inflation expectations and the consumer mood. The bank said prospective borrowers who refrained from seeking credit as they expected their application to be rejected - so-called discouraged borrowers - stood at 7.2% of those surveyed in June, from 8.5% in February. Despite the retreat, the finding for last month came in above June 2024's 5.5%. According to the New York Fed, respondents saw a higher likelihood of facing an unexpected $2,000 expense in June, while the expected ability to cover such an outlay had also risen. Other information from the bank has shown some rising stress for overall consumer-debt levels, although overall, current conditions are pretty healthy. The auto and housing markets have faced high borrowing costs as the Federal Reserve has kept its rate target relatively high to help curb inflation. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
